Safety Results Prompt Bristol To Refine Apixaban Dosing In Acute Coronary Syndrome Trials

Firm is discussing Phase III design with regulators.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet